← All curated stocks

BRISTOL MYERS SQUIBB CO (BMY)

Pharmaceutical Preparations · Pharmaceutical Preparations · NYSE

$67.61

+2.36%

Investingg Score

55.3 / 100

Hold

Business overview

  • Gross margin stands at 71.1 percent, reflecting a strong ability to retain revenue after production costs.
  • Free cash flow margin is reported at 26.7 percent, demonstrating solid cash generation capabilities relative to revenue.
  • Operating margin is unavailable in the dataset.

These metrics indicate solid operational efficiency and robust profitability on cash generation, though the missing operating margin introduces a gap in evaluating core profitability.

Financial health

  • Balance sheet pillar score is recorded at 24 out of 100.
  • Free cash flow margin is 26.7 percent.
  • Market capitalization data is unavailable as it is listed at 0.

While cash generation is strong, the low balance sheet score highlights underlying financial vulnerabilities and structural debt or coverage risks.

Gross Margin
71.1%
Operating Margin
Data unavailable
Current Ratio
1.3x
Debt / Equity
2.32
Free Cash Flow (TTM)
$12.8B
Interest Coverage
Data unavailable

Valuation

  • Forward P/E ratio is 10.35.
  • P/E ratio is unavailable.
  • Price-to-sales ratio is listed as 0.

Trading at a forward P/E of 10.35 suggests reasonable earnings pricing, but the absence of trailing P/E and price-to-sales data leaves valuation context incomplete.

P/E (TTM)
Data unavailable
Forward P/E
10.3x
Price / Sales
0.0x
EV / EBITDA
Data unavailable
FCF Yield
Data unavailable

Key risks

  • Revenue growth year-over-year is negative at -0.2 percent.
  • Balance sheet pillar score is low at 24 out of 100.
  • Certain valuation metrics such as P/E and operating margin are unavailable.

Market cap $0 · data as of 2026-08-19

Related stocks

Get the full interactive report

Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.

Analyze BMY with Investingg AI

Not investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.